We are live on ! Find out more
NRG

Nemes Rush Group Portfolio holdings

AUM $1.05B
1-Year Est. Return 30.08%
This Fund
S&P 500
This Quarter Est. Return
+13.96%
1 Year Est. Return
+30.08%
3 Year Est. Return
+95.59%
5 Year Est. Return
10 Year Est. Return
AUM
$699M
AUM Growth
+$78.2M
Cap. Flow
+$6.03M
Cap. Flow %
0.86%
Top 10 Hldgs %
33.65%
Holding
711
New
49
Increased
151
Reduced
133
Closed
44

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$11.2M
2
LLY icon
Eli Lilly
LLY
+$7.42M
3
UNP icon
Union Pacific
UNP
+$4.3M
4
MRK icon
Merck
MRK
+$1.57M
5
BBY icon
Best Buy
BBY
+$1.41M

Sector Composition

Rank Sector Weight
1 Technology 31.7%
2 Financials 14.76%
3 Healthcare 11.61%
4 Industrials 11.43%
5 Consumer Discretionary 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FVD icon
276
First Trust Value Line Dividend Fund
FVD
$8.46B
$48.1K 0.01%
1,140
MRSH
277
Marsh
MRSH
$91.7B
$47.6K 0.01%
231
SCHF icon
278
Schwab International Equity ETF
SCHF
$65.5B
$46.9K 0.01%
2,404
+1,244
+107% +$23.3K
VWO icon
279
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$46K 0.01%
1,101
+217
+25% +$8.86K
SCHB icon
280
Schwab US Broad Market ETF
SCHB
$42.9B
$46K 0.01%
2,259
+1,428
+172% +$27.6K
LYG icon
281
Lloyds Banking Group
LYG
$87.2B
$45.8K 0.01%
17,679
ASML icon
282
ASML
ASML
$608B
$45.6K 0.01%
47
+2
+4% +$1.77K
TPSC icon
283
Timothy Plan US Small Cap Core ETF
TPSC
$364M
$45.5K 0.01%
1,240
ADI icon
284
Analog Devices
ADI
$178B
$45.3K 0.01%
229
+62
+37% +$11.9K
NVS icon
285
Novartis
NVS
$304B
$45.1K 0.01%
466
BKR icon
286
Baker Hughes
BKR
$58B
$44.8K 0.01%
1,338
SWAV
287
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$44.3K 0.01%
136
COP icon
288
ConocoPhillips
COP
$139B
$44K 0.01%
345
-35
-9% -$3.99K
BNY
289
Bank of New York Mellon
BNY
$106B
$43.8K 0.01%
761
INMD icon
290
InMode
INMD
$889M
$43.8K 0.01%
2,029
XYZ
291
Block Inc
XYZ
$49.5B
$43.1K 0.01%
509
TRV icon
292
Travelers Companies
TRV
$82.9B
$42.6K 0.01%
185
FSLR icon
293
First Solar
FSLR
$21.8B
$42.5K 0.01%
+252
New +$38.7K
SNY icon
294
Sanofi
SNY
$109B
$42.4K 0.01%
872
+64
+8% +$3.13K
AVDV icon
295
Avantis International Small Cap Value ETF
AVDV
$18.8B
$41.8K 0.01%
635
+588
+1,251% +$36.7K
TAK icon
296
Takeda Pharmaceutical
TAK
$56B
$41.7K 0.01%
3,003
+282
+10% +$4.1K
LQD icon
297
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.5B
$41.6K 0.01%
382
CMI icon
298
Cummins
CMI
$88.5B
$41.3K 0.01%
140
PGR icon
299
Progressive
PGR
$128B
$41.2K 0.01%
+199
New +$36.9K
IBKR icon
300
Interactive Brokers
IBKR
$40.5B
$41.1K 0.01%
+1,472
New +$36.7K

Similar funds

Nemes Rush Group's Q1 2024 Portfolio in Review

As of Q1 2024, Nemes Rush Group held 711 positions worth $699M, up 13% from $620M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Nemes Rush Group's Q1 2024 filing shows 49 new, 151 increased, 133 reduced and 44 closed positions. Its largest new stake was RB Global: 1,308 shares worth $99.6K. The largest sale was Medtronic, an estimated $9.97M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

  • Nemes Rush Group's largest Q1 2024 buy was RB Global: 1,308 shares worth $99.6K.
  • Nemes Rush Group added most to Novo Nordisk in Q1 2024, an estimated $11.2M increase.
  • Nemes Rush Group's biggest Q1 2024 reduction was Medtronic, cutting an estimated $9.97M.
  • Nemes Rush Group fully exited Splunk Inc in Q1 2024, selling an estimated $955K.
  • Nemes Rush Group's ten largest holdings make up 34% of its $699M portfolio in Q1 2024.
  • Nemes Rush Group opened 49 new positions and closed 44 in Q1 2024.
  • Nemes Rush Group's portfolio value rose 13% quarter-over-quarter to $699M.

Based on Nemes Rush Group's 13F filing for Q1 2024, filed 15 May 2024.